Financial reports
10-K
2023 FY
Annual report
22 Feb 24
10-Q
2023 Q3
Quarterly report
26 Oct 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
10-K
2022 FY
Annual report
23 Feb 23
10-Q
2022 Q3
Quarterly report
27 Oct 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
17 Feb 22
10-Q
2021 Q3
Quarterly report
28 Oct 21
Current reports
8-K
Other Events
11 Mar 24
8-K
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
22 Feb 24
8-K
Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
5 Jan 24
8-K
Insmed Reports Third-Quarter 2023 Financial Results and Provides Business Update
26 Oct 23
8-K
Regulation FD Disclosure
5 Sep 23
8-K
Insmed Reports Second-Quarter 2023 Financial Results and Provides Business Update
3 Aug 23
8-K/A
Submission of Matters to a Vote of Security Holders
7 Jul 23
8-K
Departure of Directors or Certain Officers
11 May 23
8-K
Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, “The
8 May 23
8-K
Insmed Reports First Quarter 2023 Financial Results and Provides Business Update
4 May 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
22 Feb 24
S-8
Registration of securities for employees
19 May 23
S-3ASR
Automatic shelf registration
19 May 23
424B5
Prospectus supplement for primary offering
19 Oct 22
S-8
Registration of securities for employees
19 May 22
S-8
Registration of securities for employees
19 May 21
424B5
Prospectus supplement for primary offering
11 May 21
424B5
Prospectus supplement for primary offering
11 May 21
FWP
Free writing prospectus
11 May 21
424B5
Prospectus supplement for primary offering
10 May 21
Proxies
DEFA14A
Additional proxy soliciting materials
1 Apr 24
DEF 14A
Definitive proxy
1 Apr 24
DEFA14A
Additional proxy soliciting materials
31 Mar 23
DEF 14A
Definitive proxy
31 Mar 23
DEFA14A
Additional proxy soliciting materials
1 Apr 22
DEF 14A
Definitive proxy
1 Apr 22
DEFA14A
Additional proxy soliciting materials
1 Apr 21
DEF 14A
Definitive proxy
1 Apr 21
DEFA14A
Additional proxy soliciting materials
31 Mar 20
DEF 14A
Definitive proxy
31 Mar 20
Other
SEC STAFF
SEC staff action: Order
29 Mar 21
SEC STAFF
SEC staff action: Order
1 Mar 21
UPLOAD
Letter from SEC
5 Jan 21
CORRESP
Correspondence with SEC
30 Dec 20
UPLOAD
Letter from SEC
21 Dec 20
UPLOAD
Letter from SEC
23 Jan 20
CORRESP
Correspondence with SEC
21 Jan 20
UPLOAD
Letter from SEC
14 Jan 20
CORRESP
Correspondence with SEC
17 Dec 19
UPLOAD
Letter from SEC
4 Dec 19
Ownership
4
William Lewis
29 Feb 24
4
MELVIN MD SHAROKY
29 Feb 24
SC 13G/A
T. Rowe Price Investment Management, Inc.
16 Feb 24
SC 13G
T. Rowe Price Investment Management, Inc.
14 Feb 24
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
BlackRock Inc.
25 Jan 24
SC 13G/A
STATE STREET CORP
22 Jan 24
4
Martina M.D. Flammer
12 Jan 24
4
Roger Adsett
12 Jan 24